Evidence map›Paper›PMID 42575116›Full record

ArticleThe Lancet. Global health2026

Causes of mortality and severe morbidity in young children in Sierra Leone: a prospective cohort study.

Kwabena Owusu-Kyei, Maria Cussó, Augustin Eric Fombah, Llorenç Quintó, Andreu Bofill, Alba Morató, Victoria Fumadó, Mohamed Samai, Clara Menéndez, ICARIA Safety Team

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in The Lancet. Global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04235816 (Evaluation of the Impact on Childhood Mortality of Azithromycin Plus Intermittent Preventive Treatment Administered Through the Expanded Program on Immunization in Sierra Leone), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04235816 phase3active not recruitingnot on this map

Evaluation of the Impact on Childhood Mortality of Azithromycin Plus Intermittent Preventive Treatment Administered Through the Expanded Program on Immunization in Sierra Leone

TypeinterventionalSponsorBarcelona Institute for Global HealthRan2021 to 2026Enrolled20,560ConditionsChild MortalityArmsAzithromycin, Placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kwabena Owusu-KyeiBarcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone. Electronic address: kwabena.owusukyei@isglobal.org.
Maria CussóHospital Sant Joan de Déu, Barcelona, Spain.
Augustin Eric FombahBarcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Llorenç QuintóBarcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.
Andreu BofillBarcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain.
Alba MoratóBarcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Victoria FumadóBarcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Hospital Sant Joan de Déu, Barcelona, Spain.
Mohamed SamaiCollege of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Clara MenéndezBarcelona Institute for Global Health, Hospital Clinic-University of Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.
ICARIA Safety Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccurate data on morbidity and mortality in children younger than 2 years remain scarce in many low-income and middle-income countries. We aimed to examine the causes and risk factors for severe morbidity and mortality in young children in Sierra Leone.

methodsWe conducted a prospective cohort study nested within a randomised controlled trial (NCT04235816). The study was done in 14 primary health facilities in three districts in Sierra Leone. We enrolled infants aged 6-10 weeks, eligible for pentavalent vaccine dose 1 through the EPI programme, weighing at least 2·5 kg, resident in the study area, without known contraindications to macrolides or sulfadoxine-pyrimethamine, between March 17, 2021, and April 25, 2024. The objective was to assess causes of hospital admission and death through to Dec 31, 2024, when approximately 80% of children had completed 18-month follow-up. Hospital admissions, deaths, and immunisation status were captured through facility surveillance, household visits, telephone follow-ups, and community informants. Causes of death were classified using ICD-10 and the WHO 2016 verbal autopsy tool (InSilicoVA). Incidence rates were expressed per 1000 child-months at risk. Morbidity was analysed using negative binomial regression; in-hospital mortality was analysed using penalised logistic regression, and post-discharge mortality was analysed using Cox proportional hazards regression.

findingsData on severe morbidity and mortality were collected from 20 560 children, of whom 10 644 (52%) were male and 9916 (48%) were female; the most common ethnicity was Temne (14 048 [68%] of 20 551 children with available data). Median follow-up was 16·6 months (IQR 16·0-16·7). There were 2688 hospital admissions (excluding readmissions and in-hospital deaths), yielding an incidence of 8·67 per 1000 child-months at risk (95% CI 8·35-9·00). Malaria (1459 [54·3%] of 2688 admissions), lower respiratory tract infections including pneumonia (449 [16·7%]), diarrhoea (259 [9·6%]), undernutrition (198 [7·4%]), and sepsis (128 [4·8%]) were the leading causes of admission. The leading causes of in-hospital deaths were malaria (122 [50·6%] of 241), lower respiratory tract infections (41 [17·0%]), sepsis (33 [13·7%]), undernutrition (17 [7·1%]), and diarrhoea (nine [3·7%]). The leading causes of community deaths for which a verbal autopsy was performed were malaria (103 [24·2%] of 425), lower respiratory tract infections (76 [17·9%]), other infectious diseases (73 [17·2%]), and diarrhoea (54 [12·7%]). Post-discharge mortality was 33·8 per 1000 child-months at risk (95% CI 27·08-42·20). Being underweight was associated with higher in-hospital mortality compared with not being underweight (adjusted odds ratio [OR] 1·60 [95% CI 1·21-2·12]). Full immunisation was associated with lower overall mortality (adjusted hazard ratio [HR] 0·65 [95% CI 0·55-0·76]), lower in-hospital mortality (adjusted OR 0·71 [95% CI 0·54-0·95]), and lower post-discharge mortality (adjusted HR 0·56 [95% CI 0·33-0·92]).

interpretationThis study shows that despite major investments and implementation efforts, mortality in infants and young children in Sierra Leone remains high and predominantly caused by preventable infections. These findings highlight the substantial unfinished agenda in global health and the urgent need for more effective tools and strategies.

fundingGates Foundation and La Caixa Foundation.

Indexed as

Cause of DeathHospitalizationInfant MortalityCohort StudiesFemaleHumansInfantMaleMorbidityProspective StudiesRisk FactorsSierra Leone

Identifiers

PMID42575116
PMCPMC13652798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.